5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.27▲ | 4.20▲ | 4.15▲ | 4.01▼ | 4.26▼ |
MA10 | 4.17▲ | 4.10▲ | 4.09▲ | 4.10▼ | 5.02▼ |
MA20 | 4.23▲ | 4.24▲ | 4.24▲ | 4.24▼ | 4.92▼ |
MA50 | 4.34▲ | 4.44▼ | 4.68▼ | 5.01▼ | N/A |
MA100 | 4.87▼ | 5.44▼ | 5.46▼ | N/A | N/A |
MA200 | 5.77▼ | 5.36▼ | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.045▲ | 0.033▲ | 0.036▲ | 0.005▲ | N/A |
RSI | 53.691▲ | 51.247▲ | 50.451▲ | 38.662▼ | 38.391▼ |
STOCH | 94.637▲ | 56.546 | 43.120 | 20.650 | 10.268▼ |
WILL %R | -6.154▲ | -55.147 | -55.147 | -80.503▼ | -93.333▼ |
CCI | 141.495▲ | 36.217 | 24.993 | -35.524 | -89.140 |
Tuesday, April 29, 2025 06:30 AM
Access detailed historical stock prices, including daily closing prices, for RADX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
|
Monday, April 28, 2025 05:00 AM
Phase 2b study evaluating diagnostic performance of 18F-RAD101 for suspected recurrent brain metastases from solid tumors of different origins Underscores Radiopharm’s commitment to developing ...
|
Thursday, April 24, 2025 05:00 PM
Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable biodistribution and low uptake in non-target ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 4.25 | 4.50 | 3.99 | 4.00 | 54,900 |
30/04/25 | 4.00 | 4.14 | 3.91 | 3.91 | 18,300 |
28/04/25 | 3.86 | 4.353 | 3.86 | 3.99 | 5,800 |
25/04/25 | 4.19 | 4.19 | 4.06 | 4.07 | 4,103 |
24/04/25 | 4.05 | 4.30 | 4.05 | 4.09 | 2,100 |
23/04/25 | 4.30 | 4.30 | 3.69 | 4.05 | 34,304 |
22/04/25 | 4.252 | 4.44 | 3.99 | 4.21 | 47,500 |
21/04/25 | 4.13 | 4.36 | 4.04 | 4.20 | 12,900 |
17/04/25 | 4.36 | 5.28 | 4.1301 | 4.30 | 23,295 |
16/04/25 | 4.29 | 4.5002 | 3.945 | 4.20 | 84,092 |
|
|
||||
|
|
||||
|
|